Scott M. Giacobello's Net Worth

$1.93 Million

Estimate Recalculated Sep 8, 2024 07:33PM EST

Who is Scott M. Giacobello?

Scott M. Giacobello has an estimated net worth of $1.93 Million. This is based on reported shares across multiple companies, which include Aadi Bioscience, Inc., and GW PHARMACEUTICALS PLC.

SEC CIK

Scott M. Giacobello's CIK is 0001754154

Past Insider Trading and Trends

2019 was Scott M. Giacobello's most active year for acquiring shares with 8 total transactions. Scott M. Giacobello's most active month to acquire stocks was the month of February. 2021 was Scott M. Giacobello's most active year for disposing of shares, totalling 18 transactions. Scott M. Giacobello's most active month to dispose stocks was the month of April. 2022 saw Scott M. Giacobello paying a total of $250,000.00 for 66,400 shares, this is the most they've acquired in one year. In 2021 Scott M. Giacobello cashed out on 1,042,392 shares for a total of $1,456,823.40, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Aadi Bioscience, Inc. (AADI) Snapshot price: $1.82

CHIEF FINANCIAL OFFICER

Scott M. Giacobello owns 20,000 units of Common Stock which is worth $36,400.00. In the year 2023 Scott M. Giacobello acquired a total of 20,000 shares in Aadi Bioscience, Inc. at a cost of $250,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Mar 1
Form 4
∞
20K
$12.50
$250,000.00
20K
Sep 26
Form 4
—
0
—
—
0
Apr 1
Form 3
—
0
—
—
0
No matching records found

GW PHARMACEUTICALS PLC No price found

Chief Financial Officer

Scott M. Giacobello used to own units in Ordinary Shares but no longer holds any shares there.acquired a total of 297,792 shares in GW PHARMACEUTICALS PLC at a cost of $49,341.66, Scott also disposed a total of 319,848 shares of GW PHARMACEUTICALS PLC equalling to $2,196,197.76.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-165.11K
—
—
0
May 5
Form 4
—
0
—
—
0
Mar 2
Form 4
+17.64%
74.05K
$17.88
-$1,456,605.78
493.8K
Feb 26 - Mar 1
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Jun 4
Form 4
+182.15%
58.79K
$9.67
-$558,940.80
91.06K
May 18
Form 4
+8.89%
7.2K
$6.80
$48,960.00
88.22K
Mar 13
Form 4
-2.67%
-2.22K
$8.34
-$18,514.80
81.02K
Mar 2
Form 4
-4.42%
-3.85K
$9.17
-$35,322.84
83.24K
Feb 26
Form 4
+4.70%
3.91K
$14.52
-$61,321.90
87.1K
May 18 - May 20
Form 4
—
0
—
—
0
Mar 1
Form 4
+96.42%
5.17K
$12.45
-$65,109.99
10.54K
Feb 26
Form 3
—
0
—
—
0
No matching records found